Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-25-000897
Filing Date
2025-10-10
Accepted
2025-10-10 19:55:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 33831
2 JOINT FILING AGREEMENT ss5449757_ex9901.htm EX-99.1 12938
  Complete submission text file 0000947871-25-000897.txt   48544
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE

Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Subject) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90283 | Film No.: 251389030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)